November 30, 2023
Headlines

Therapy

FDA Grants Regenerative Medication Superior Remedy (RMAT) designation to Autolus’ CAR T cell remedy, obe-cel, for the remedy of grownup B-ALL

Helena Musk09 mins

Autolus Restricted LONDON, April 25, 2022 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical firm creating next-generation programmed T cell therapies, right this moment introduced that the U.S. Meals and Drug Administration (FDA) has granted Regenerative Medication Superior Remedy (RMAT) designation to its lead gene remedy obecabatagene autoleucel (obe-cel), a CD19-directed autologous…

Read More

European Medicines Company Commences Evaluation of Novel Gene Remedy Candidate Etranacogene Dezaparvovec for Individuals with Hemophilia B

Helena Musk013 mins

Advertising and marketing Authorization Software (MAA) for etranacogene dezaparvovec might be reviewed beneath accelerated evaluation and has the potential to be the primary gene remedy for sufferers dwelling with hemophilia B MAA submitting is supported by the section 3 HOPE-B examine which demonstrated sturdy and sustained therapeutic impact after a single infusion Milestone underscores CSL…

Read More

May New Remedy for Meals ‘Cues’ Enhance Weight Loss?

Helena Musk012 mins

An intensive 1-year habits remedy program aimed toward altering an individual’s response to meals “cues” would possibly assist folks with obesity lose a modest quantity of weight, a randomized scientific trial suggests. “Sufferers who’re food-cue delicate typically really feel uncontrolled with their consuming; they can’t resist meals and/or can’t cease interested by meals,” stated lead creator…

Read More